Table 2.

Baseline FDG delivery, flux, and SUV measures versus clinical and pathologic breast tumor features

K1, mL/min/gKi, mL/min/gSUV
CharacteristicMeanSDPMeanSDPMeanSDP
Tumor histology
 Ductal0.1330.0490.920.0250.018<0.00015.062.93<0.0001
 Lobular0.1300.0700.0060.0022.250.52
Clinically positive nodes
 No0.1230.0500.400.0250.0210.675.143.310.70
 Yes0.1350.0510.0230.0184.772.85
Menopausal status
 Pre0.1320.0520.890.0240.0190.584.943.090.67
 Post0.1340.0500.0220.0174.652.64
Tumor grade
 I0.1530.0700.540.0080.0050.0032.620.810.006
 III0.1310.0500.0180.0133.962.32
 III0.1310.0500.0290.0205.673.12
ER expression
 Positive0.1340.0580.820.0170.0120.00083.822.210.001
 Negative0.1310.0410.0310.0216.063.22
PR expression
 Positive0.1310.0580.770.0160.0110.00093.621.800.0004
 Negative0.1340.0450.0290.0215.843.28
HER-2/neu
 Positive0.1330.0520.860.0250.0200.165.123.160.12
 Negative0.1350.0510.0190.0134.112.01
Ki-67 proliferative index
 Other than high0.1420.0600.460.0120.0090.00013.101.080.0002
 High0.1290.0500.0260.0195.162.94